Position in APYX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$98,928
+$24,726 QoQ
Shares Held
22,033
+9.6% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 67 holders
Holding Since
Sep 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APYX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $5,528,127,448 across 46 Medical Devices names. APYX ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
18,806,911 | $1,706,539,098 | |
| 2 | MDT |
Medtronic plc
|
17,550,983 | $1,373,013,392 | |
| 3 | SYK |
Stryker Corp
|
2,787,785 | $877,706,223 | |
| 4 | BSX |
Boston Scientific Corp
|
13,772,323 | $587,802,740 | |
| 5 | BRKR |
Bruker Corp
|
3,429,337 | $283,923,498 | |
| 6 | DXCM |
Dexcom Inc
|
3,595,893 | $242,183,387 | |
| 7 | EW |
Edwards Lifesciences Corp
|
1,034,154 | $93,549,566 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
193,682 | $56,866,970 |
All Filings in APYX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,928 | 22,033 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $74,202 | 20,109 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $90,793 | 25,941 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $58,826 | 27,489 | Shares | Defined | 2025-11-13 | |
| 2022-03-31 | $352,221 | 53,939 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $691,497 | 53,939 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $747,900 | 54,000 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||